Users of this system, can login to view this document.


Enter the following information to request a copy of the document from the responsible person.

Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced non-small cell lung cancer: the PROLUNG Phase 2 randomized clinical trial

This email address is used for sending the document.